Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target. [electronic resource]
Producer: 20170313Description: 695-702 p. digitalISSN:- 1872-7913
- Animals
- Antiprotozoal Agents -- administration & dosage
- Cell Line
- Chalcone -- administration & dosage
- Cricetinae
- DNA, Protozoan -- genetics
- DNA, Ribosomal -- genetics
- Disease Models, Animal
- Drug Evaluation, Preclinical -- methods
- Female
- Flow Cytometry -- methods
- Genes, Reporter
- Hydrazones -- administration & dosage
- Leishmania donovani -- drug effects
- Leishmaniasis, Visceral -- drug therapy
- Luminescent Proteins -- analysis
- Macrophages -- parasitology
- Male
- Mice
- RNA, Ribosomal, 18S -- genetics
- Recombination, Genetic
- Staining and Labeling -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.